Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Wells Fargo Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $110
Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries
J.P. Morgan's Top Healthcare Stocks for 2025
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Here's Why Boston Scientific (NYSE:BSX) Has Caught The Eye Of Investors
Boston Scientific Hits 4-week Low
RBC Capital Maintains Boston Scientific(BSX.US) With Buy Rating, Raises Target Price to $105
Boston Sci Issues Safety Recall for POLARx Cryoablation Catheters
Express News | Boston Scientific Shares Extend Losses, Last Down 1.7% at $88.90
Express News | FDA: There Have Been Seven Reported Injuries & Four Reports of Death Related to Boston Scientific's Polarx Cryoablation Balloon Catheters
Express News | FDA: Boston Scientific Updates Use Instructions for Polarx & Polarx Fit Cryoablation Balloon Catheters Over Many Reports of Atrio-Esophageal Fistula
Least Shorted S&P 500 Stocks in November
Truist Financial Maintains Boston Scientific(BSX.US) With Buy Rating, Announces Target Price $110
Pain Management Devices Global Analysis Report 2024-2034 Featuring Abbott Laboratories, Boston Scientific, Medtronic, Nevro, Baxter, OMRON, Stryker, Teleflex, ICU Medical, AtriCure, and Zynex
Boston Scientific (BSX) Stock Moves -0.03%: What You Should Know
Morgan Stanley Maintains Boston Scientific(BSX.US) With Buy Rating, Maintains Target Price $100
Optimistic Outlook for Boston Scientific's Urology Segment Drives Buy Recommendation
FDA Roundup: December 17, 2024